Sergio Fragoso-Saavedra

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, Laura E. Hernández‐Vanegas et al. · Clinical Immunology · 2021 · 116 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +12

Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study

Isaac Núñez, Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga et al. · The Lancet Regional Health - Americas · 2022 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +12

Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study

Isaac Núñez, Joshua Gillard, Sergio Fragoso-Saavedra et al. · Frontiers in Medicine · 2023 · 18 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +15

A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol

Sergio Fragoso-Saavedra, David A. Iruegas-Nunez, Alejandro Quintero-Villegas et al. · BMC Infectious Diseases · 2020 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14